Riggs Josh - Insider Non-Derivative Transactions at Oncocyte Corp (OCX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Apr 11, 2024, Riggs Josh's relationship to Oncocyte Corp (OCX) is Director,Officer (CEO and President), and currently has 3,505 shares of Common Stock, no par value.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OCX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Riggs Josh - Insider Non-Derivative Transactions of OCX Common Stock, no par value

Riggs Josh - Insider Non-Derivative Transactions at OCX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Apr 12, 2024	P -- (Common Stock, no par value)	3390	2.95	3505